Skip to main content

Corporate insider profile

Ken Herrmann Insider Trades

Latest reported as Director of Aktis Oncology, Inc. (AKTS).

Purchase filings
0
Reported companies
1
Net open-market value
-$196,532.58
Latest transaction
Jul 20, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jul 20, 2026Aktis Oncology, Inc. (AKTS)DirectorSale4,856$24.56$119,274
Jul 17, 2026Aktis Oncology, Inc. (AKTS)DirectorSale3,065$25.21$77,259